Pancytopenia Following Use of Hydrallazine ("Apresoline")

Q: What does this research mean for the field?

The use of the antihypertensive drug hydrallazine can lead to the development of pancytopenia as a severe adverse effect. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

Manuel Kaufman

doi:10.1001/jama.1953.02940170024007

April 25, 1953Journal of the American Medical Association

Pancytopenia Following Use of Hydrallazine ("Apresoline")

View at Publisher

Ask AI

Bookmark

Share

Why the study?

Does hydralazine cause pancytopenia in patients treated for hypertension?

Structured PICO

Does hydralazine cause pancytopenia in patients treated for hypertension?

P

Population

A 44-year-old woman with a 20-year history of hypertension (developed following bilateral chronic nephritis during pregnancy).

I

Intervention

Hydralazine

O

Outcome

Pancytopeniasafety

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Hydralazine use for hypertension may be associated with the development of pancytopenia.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Manuel Kaufman (1953) studied this question.

synapsesocial.com/papers/6a12ff068793652519a6aad3 https://doi.org/10.1001/jama.1953.02940170024007

View at Publisher

Ask AI

Bookmark

Share

Pancytopenia Following Use of Hydrallazine ("Apresoline")

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Pancytopenia Following Use of Hydrallazine ("Apresoline")

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading